Opinion|Videos|January 9, 2024
Optimizing Drug Delivery Methods With Nanotechnologies
Author(s)Ascendia Pharma
Shaukat Ali, PhD, Senior Director of Scientific Affairs and Technical Marketing, Ascendia Pharmaceuticals, highlights the benefits of the company’s nanotechnologies in supporting formulation development of poorly soluble molecules.
Shaukat Ali, PhD, Senior Director of Scientific Affairs and Technical Marketing, Ascendia Pharmaceuticals, discusses:
- Capabilities related to formulation development and manufacturing of cGMP batches
- Considerations in the development of formulations for poorly soluble molecules
- Role of nanotechnologies to optimize drug delivery methods, such as long-acting injectables
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Navigating AI, Sustainability, and Operational Resilience
2
Pharmaceutical Supply Chain Resilience in a Shifting Market
3
Single-Use Systems Enable Commercial-Scale CGT Manufacturing
4
Jubilant Biosys Announces New Facility in India
5